comparing the effectiveness between 2 ureteral stents- 5Fr vs 6Fr
Phase 4
- Conditions
- Health Condition 1: N201- Calculus of ureter
- Registration Number
- CTRI/2023/11/059605
- Lead Sponsor
- Dr Nisanth Puliyath
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age >18 years
2. Patients undergoing unilateral semi-rigid URS or retrograde intrarenal surgery (RIRS) with planned ureteral stent insertion for urinary tract stones
Exclusion Criteria
Age < 18 years
2. Pregnant patients
3. Breastfeeding
4. Involvement in bilateral procedures
5. concomitant use of confounding medications
6. acive urinary tract infection
7. comorbid urologic malignancy
8. comorbid urologic anatomical abnormalities and conditions, such as ureteral stricture
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method •To assess the stent-related symptoms as different domain scores, as recorded by the USSQs in patients undergoing ureteric stenting. <br/ ><br>•To compare the USSQ scores between the stent sizes 5 Fr and 6 Fr in different domains like general health, work performance, sexual function, and global quality of life scores recorded by the USSQs. <br/ ><br>Timepoint: Different domain scores, as recorded by the USSQs in patients undergoing ureteric stenting at TWO TIME POPINTS: <br/ ><br> <br/ ><br>After 1 week of stenting (with stent in-situ) and 2 weeks after stent removal
- Secondary Outcome Measures
Name Time Method To analyze hydronephrosis, analgesics usage & post operative complications in stented patients. <br/ ><br>To compare the stone-free rates between 5 Fr & 6 Fr stent sizes. <br/ ><br>•To propose the ideal stent diameter to be used in patients after ureterorenoscopy <br/ ><br> <br/ ><br>Timepoint: 4 WEEKS